Memphis Grizzlies forward Santi Aldama will undergo a season-ending arthroscopic procedure to address discomfort in his right knee, the team announced Monday. The procedure will be accompanied by an orthobiologic injection, aiming to provide long-term relief and support recovery.
Aldama, who has been sidelined since February 4th following a game against the Sacramento Kings, experienced a setback in his attempted return to play earlier this month. He was initially slated to rejoin the lineup against the Minnesota Timberwolves on March 3rd but was ruled out shortly before tip-off after a concerning pregame workout, according to reports. Further attempts to return against the Trail Blazers and Los Angeles Clippers were also unsuccessful.
The decision to proceed with surgery marks the end of a frustrating season for the fifth-year pro, who had established career highs in points, rebounds, and minutes played. Prior to his injury, Aldama was averaging 14.0 points, 6.7 rebounds, and 2.9 assists in 27.9 minutes per contest across 43 appearances, according to CBS Sports. His absence has been keenly felt by a Grizzlies team already grappling with significant injury challenges.
The Grizzlies have faced a series of injuries this season to key players including Brandon Clarke, Ja Morant, and Zach Edey, but updates regarding Aldama’s condition have been less frequent and detailed, raising questions among fans and analysts. As noted in a recent report by Beale Street Bears, the lack of transparency surrounding Aldama’s injury stands in contrast to the more consistent communication provided for other injured players. Beale Street Bears highlighted this discrepancy, noting the growing concern about Aldama’s long-term availability.
The team’s lack of size and interior presence has been exacerbated by Aldama’s absence. The Grizzlies have struggled with paint scoring and defensive rebounding, areas where Aldama consistently contributed. His ability to stretch the floor and provide rebounding support will be missed as the team navigates the remainder of the season.
Whereas the season-ending procedure is a setback, the Grizzlies organization expressed optimism about Aldama’s full recovery. The use of an orthobiologic injection alongside the arthroscopic surgery suggests a proactive approach to addressing the underlying issue and promoting long-term joint health.
The Grizzlies PR team shared the update on X, formerly known as Twitter, earlier today.
The @memgrizz today announced the following medical update for Santi Aldama:
Looking ahead, the Grizzlies will focus on evaluating their remaining roster and navigating the final stretch of the season. The team will undoubtedly assess its options for bolstering its frontcourt in the offseason, with Aldama’s eventual return factored into those plans. The timeline for his complete recovery and return to full basketball activity will be determined in the coming months.
What impact will Aldama’s absence have on the Grizzlies’ playoff aspirations? Share your thoughts in the comments below.
Disclaimer: This article provides informational content about medical updates related to a professional athlete and should not be considered medical advice. Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
